Różnice między inwestowaniem a handlem
Różnice między inwestowaniem a handlem
Pfizer is an American pharmaceutical company with a long and successful history. It was founded in 1849 by two German immigrants, Charles Pfizer and Charles Erhardt. The company went public in 1963 and has since become one of the largest pharmaceutical companies in the world. Pfizer's products include some of the most well-known and trusted brands in the industry, such as Advil, Viagra, and Lipitor. In recent years, Pfizer has been working to expand its product line beyond traditional medications and into areas such as vaccines and cancer treatments.
The Covid-19 pandemic has presented both challenges and opportunities for Pfizer. On the one hand, the company's factories have been working around the clock to produce vaccines and other treatments for the disease. On the other hand, many of Pfizer's products are used to treat conditions that have become more common during the pandemic, such as anxiety and depression. As a result, Pfizer's sales and profits have been strong in recent years.
Pfizer's share price has been on a rollercoaster ride over the past few years. After hitting an all-time high in early 2020, the stock plunged in the wake of the Covid-19 pandemic. However, Pfizer has since staged a strong recovery and its share price is now back near its pre-pandemic highs.
Looking ahead, Pfizer's share price is likely to be influenced by a number of factors, including the company's ongoing efforts to develop new medicines, competition from other drugmakers like Johnson & Johnson, Merck, and Novartis as well as global economic conditions.
Pfizer, Moderna and AstraZeneca are all big names in the pharmaceutical industry. Pfizer’s stock price has outperformed the market in the last 5 years. Moderna’s stock price has exploded in the last few years but is still down from its highs. AstraZeneca’s stock price has lagged the market over the last 5 years. If you're looking for a large-cap pharmaceutical stock Pfizer could be worth considering.
Investing in Pfizer stock CFDs allows you to speculate on the price movements of the underlying asset without actually owning the shares. This means that you can take a long or short position, depending on your market forecast. Trading Pfizer stock CFDs is a leveraged product, which means that you only need to put down a small deposit (margin) to open a much larger trade. This gives you the potential to make large profits, but also comes with increased risk. Please note that CFD trading involves a significant risk of loss.
When investing in Pfizer shares, you will be buying and selling the actual shares of the company. This means that if the share price goes up, you will make a profit, and if it goes down, you will make a loss. With CFD trading, you are speculating on the price movements of the underlying asset, without actually owning it. This means that you can take a long or short position, depending on your market forecast.
|Swap dla długiej pozycji||[[ data.swapLong ]] punkty|
|Swap dla krótkiej pozycji||[[ data.swapShort ]] punkty|
|Minimalny spread||[[ data.stats.minSpread ]]|
|Średni spread||[[ data.stats.avgSpread ]]|
|Minimalny rozmiar kontraktu||[[ data.minVolume ]]|
|Minimalny krok||[[ data.stepVolume ]]|
|Prowizja i swap||Prowizja i swap|
|Godziny handlu||Godziny handlu|
* Podane spready przedstawiają średnią ważoną czasem. Chociaż Skilling próbuje zapewnić konkurencyjne spready we wszystkich godzinach handlu, klienci powinni pamiętać, że mogą się one różnić i są zależne od warunków panujących na rynkach bazowych. Powyższe dane podano jedynie w celach informacyjnych. Zalecamy klientom sprawdzanie wiadomości o ważnych wydarzeniach w naszym Kalendarzu Ekonomicznym. Mogą one skutkować m.in. poszerzeniem spreadów.
Powyższe spready mają zastosowanie podczas normalnych warunków handlowych. Skilling ma prawo do zmiany powyższych spreadów w zależności od warunków handlowych, zgodnie z 'Regulaminem'.
Dlaczego warto handlować [[data.name]]
Wykorzystaj w pełni fluktuacje cen – bez względu na kierunek, w którym cena się zmienia i bez ograniczeń kapitałowych, które wiążą się z zakupem aktywów bazowych.